The rise of antimicrobial resistance has been accompanied by a decline in the development of new antibiotics. In this article, we explore the current state of affairs and trends in both human- and animal-related antibiotic development activity, with distinct differences between the two sectors.
No takes yet. Share an insight, caveat, or question.
Ogunniyi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: